2.200 Å
X-ray
1995-03-31
| Name: | Gag-Pol polyprotein |
|---|---|
| ID: | POL_HV1B1 |
| AC: | P03366 |
| Organism: | Human immunodeficiency virus type 1 group M subtype B |
| Reign: | Viruses |
| TaxID: | 11678 |
| EC Number: | / |
| Chain Name: | Percentage of Residues within binding site |
|---|---|
| A | 50 % |
| B | 50 % |
| B-Factor: | 17.630 |
|---|---|
| Number of residues: | 40 |
| Including | |
| Standard Amino Acids: | 40 |
| Non Standard Amino Acids: | 0 |
| Water Molecules: | 0 |
| Cofactors: | |
| Metals: | |
| Ligandability | Volume (Å3) |
|---|---|
| 0.662 | 786.375 |
| % Hydrophobic | % Polar |
|---|---|
| 42.49 | 57.51 |
| According to VolSite | |

| HET Code: | C20 |
|---|---|
| Formula: | C31H51N5O5 |
| Molecular weight: | 573.767 g/mol |
| DrugBank ID: | - |
| Buried Surface Area: | 65.53 % |
| Polar Surface area: | 139.86 Å2 |
| Number of | |
|---|---|
| H-Bond Acceptors: | 6 |
| H-Bond Donors: | 5 |
| Rings: | 2 |
| Aromatic rings: | 1 |
| Anionic atoms: | 0 |
| Cationic atoms: | 0 |
| Rule of Five Violation: | 1 |
| Rotatable Bonds: | 15 |
| X | Y | Z |
|---|---|---|
| 5.25739 | -1.53798 | 14.0348 |
Image generated by PoseView
Represent the protein/ligand binding mode, centered on the ligand
Dashed lines represents hydrogen bonds and metal interactions
Green residue labels for amino acids with hydrophobic contacts (green lines) to the ligand
| Ligand | Protein | Interaction | |||
|---|---|---|---|---|---|
| Atom | Atom | Residue | Distance (Å) | Angle (°) | Type |
| C15 | CD2 | LEU- 23 | 3.94 | 0 | Hydrophobic |
| O21 | OD2 | ASP- 25 | 2.96 | 143.28 | H-Bond (Ligand Donor) |
| O21 | OD1 | ASP- 25 | 2.53 | 130.12 | H-Bond (Ligand Donor) |
| N11 | O | GLY- 27 | 2.95 | 152.23 | H-Bond (Ligand Donor) |
| N31 | O | GLY- 27 | 3.14 | 160.08 | H-Bond (Ligand Donor) |
| C7 | CB | ALA- 28 | 4.03 | 0 | Hydrophobic |
| C37 | CB | ALA- 28 | 3.79 | 0 | Hydrophobic |
| O3 | N | ASP- 29 | 2.91 | 162.45 | H-Bond (Protein Donor) |
| O40 | N | ASP- 29 | 2.89 | 165.28 | H-Bond (Protein Donor) |
| C38 | CB | ASP- 30 | 4.27 | 0 | Hydrophobic |
| C7 | CG2 | VAL- 32 | 4.31 | 0 | Hydrophobic |
| C8 | CG2 | VAL- 32 | 3.71 | 0 | Hydrophobic |
| C37 | CG2 | VAL- 32 | 4.36 | 0 | Hydrophobic |
| C38 | CG2 | VAL- 32 | 4.15 | 0 | Hydrophobic |
| C8 | CD1 | ILE- 47 | 4.21 | 0 | Hydrophobic |
| C38 | CD1 | ILE- 47 | 4.28 | 0 | Hydrophobic |
| N4 | O | GLY- 48 | 3.09 | 165.96 | H-Bond (Ligand Donor) |
| N35 | O | GLY- 48 | 2.91 | 172.9 | H-Bond (Ligand Donor) |
| C19 | CD1 | ILE- 50 | 4.34 | 0 | Hydrophobic |
| C24 | CG1 | ILE- 50 | 4.48 | 0 | Hydrophobic |
| C26 | CG1 | ILE- 50 | 4.21 | 0 | Hydrophobic |
| C7 | CG1 | ILE- 50 | 3.99 | 0 | Hydrophobic |
| C37 | CD1 | ILE- 50 | 3.64 | 0 | Hydrophobic |
| C27 | CG | PRO- 81 | 3.92 | 0 | Hydrophobic |
| C18 | CG | PRO- 81 | 3.43 | 0 | Hydrophobic |
| C28 | CG1 | VAL- 82 | 3.5 | 0 | Hydrophobic |
| C16 | CG1 | VAL- 82 | 3.65 | 0 | Hydrophobic |
| C7 | CD1 | ILE- 84 | 3.63 | 0 | Hydrophobic |
| C24 | CD1 | ILE- 84 | 4.38 | 0 | Hydrophobic |
| C26 | CD1 | ILE- 84 | 3.8 | 0 | Hydrophobic |
| C37 | CD1 | ILE- 84 | 3.83 | 0 | Hydrophobic |
| C19 | CD1 | ILE- 84 | 4.06 | 0 | Hydrophobic |